Eloxx Pharmaceuticals, Inc. current ratio

The Current Ratio as of October 2026 (TTM) for Eloxx Pharmaceuticals, Inc. (ELOX) is 3.74

According to Eloxx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.74. This represents a change of 254.81% compared to the average of 1.05 of the last 4 quarters.

Eloxx Pharmaceuticals, Inc. (ELOX) Historical Current Ratio (quarterly & annually)

How has ELOX Current Ratio performed in the past?

The mean historical Current Ratio of Eloxx Pharmaceuticals, Inc. over the last ten years is 2.95. The current 3.74 Current Ratio has changed 26.58% with respect to the historical average. Over the past ten years (40 quarters), ELOX's Current Ratio was at its highest in in the June 2018 quarter at 14.69. The Current Ratio was at its lowest in in the March 2025 quarter at 0.

Eloxx Pharmaceuticals, Inc. (ELOX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Eloxx Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Eloxx Pharmaceuticals, Inc. (ELOX) Average Current Ratio

How has ELOX Current Ratio performed in the past?

The current Current Ratio of Eloxx Pharmaceuticals, Inc. (ELOX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Eloxx Pharmaceuticals, Inc. (ELOX) Current Ratio vs. Peers

How is ELOX’s Current Ratio compared to its peers?

Eloxx Pharmaceuticals, Inc.’s Current Ratio is greater than Nabriva Therapeutics plc (1.13), greater than NexImmune, Inc. (1.06), less than MedAvail Holdings, Inc. (4.03), less than Ormand Industries Inc (0), greater than Verde Science, Inc. (0.00), greater than Cardax, Inc. (0.11), greater than Biocept, Inc. (2.97), greater than Micron Solutions, Inc. (1.69), greater than Nutrition Management Services Company (1.39), greater than HTG Molecular Diagnostics, Inc. (1.89),

Build a custom stock screener for Eloxx Pharmaceuticals, Inc. (ELOX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eloxx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eloxx Pharmaceuticals, Inc. (ELOX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eloxx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.